Mirtazapine Tablet, Film Coated
Product Images NDC 55154-5355

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-5355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5d79b23a C888 4c99 A70c 8ecfb0376be2 00

The text describes a medication which is Mirtazapine Tablets, USP with strength 15mg and 10 tablets. The tablets are beige in color and round in shape with "M" over 515 on one side and a score on the other side. The medication guide, precautions, and warnings can be seen in the product insert. The tablets should be stored at 20° to 25° C (68° to 77° F) and should be protected from light and moisture. It is manufactured for Mylan Pharmaceuticals Inc. in Morgantown, WV and distributed by Mylan Institutional Inc. in Rockford, IL. The medication is RXONLY and is not child resistant.*

FDA Label Image

Image 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.